These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 3147416

  • 1. Effect of anti-schistosomal treatment on schistosomal-specific nephropathy.
    Sobh MA, Moustafa FE, Sally SM, Deelder AM, Ghoniem MA.
    Nephrol Dial Transplant; 1988; 3(6):744-51. PubMed ID: 3147416
    [Abstract] [Full Text] [Related]

  • 2. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A, Hill GS, Montseny JJ, Meyrier A.
    Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
    [Abstract] [Full Text] [Related]

  • 3. Oxamniquine treatment for schistosomal polyposis: a 1-2 year follow-up study.
    el-Masry NA, Farid Z, Bassily S, Kilpatrick ME, Watten RH, Girgis NI.
    J Trop Med Hyg; 1986 Feb; 89(1):19-21. PubMed ID: 3091853
    [Abstract] [Full Text] [Related]

  • 4. A prospective, randomized therapeutic trial for schistosomal specific nephropathy.
    Sobh MA, Moustafa FE, Sally SM, Foda MA, Deelder AM, Ghoneim MA.
    Kidney Int; 1989 Nov; 36(5):904-7. PubMed ID: 2515342
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of schistosomiasis mansoni with a combination of oxamniquine and praziquantel. I--Experimental observations related to the pre-patent phase].
    Campos R, Pinto PL, de Sant'Ana EJ, Moreira AA, Amato Neto V.
    Rev Hosp Clin Fac Med Sao Paulo; 1987 Nov; 42(5):201-3. PubMed ID: 3135570
    [No Abstract] [Full Text] [Related]

  • 6. The significance of focal and segmental hyalinosis and sclerosis (FSHS) and nephrotic range proteinuria in IgA nephropathy.
    Packham DK, Yan HD, Hewitson TD, Nicholls KM, Fairley KF, Kincaid-Smith P, Becker GJ.
    Clin Nephrol; 1996 Oct; 46(4):225-9. PubMed ID: 8905206
    [Abstract] [Full Text] [Related]

  • 7. Cure rates and egg reduction in treatment of intestinal schistosomiasis with oxamniquine and praziquantel in Maniema, Zaire.
    Polderman AM, Gryseels B, De Caluwe P.
    Trans R Soc Trop Med Hyg; 1988 Oct; 82(1):115-6. PubMed ID: 3140441
    [No Abstract] [Full Text] [Related]

  • 8. Characterisation of kidney lesions in early schistosomal-specific nephropathy.
    Sobh MA, Moustafa FE, Sally SM, Deelder AM, Ghoniem MA.
    Nephrol Dial Transplant; 1988 Oct; 3(4):392-8. PubMed ID: 3140123
    [Abstract] [Full Text] [Related]

  • 9. Randomized comparative trials of single doses of the newer antischistosomal drugs at Mwanza, Tanzania. I. Praziquantel and oxamniquine for the treatment of schistosomiasis mansoni.
    Rugemalila JB, Asila J, Chimbe A.
    J Trop Med Hyg; 1984 Dec; 87(6):231-5. PubMed ID: 6398833
    [Abstract] [Full Text] [Related]

  • 10. Clinicopathologic analysis of renal biopsies after haematopoietic stem cell transplantation.
    Chan GS, Lam MF, Au WY, Chim S, Tse KC, Lo SH, Fung SH, Lai KN, Chan KW.
    Nephrology (Carlton); 2008 Jun; 13(4):322-30. PubMed ID: 18221254
    [Abstract] [Full Text] [Related]

  • 11. Ultrasonographic profile of the liver and caliber of portal vein after oral antibilharzial drugs.
    el-Hawey AM, Wahib AA, Ossman OM, el Zahaby AA.
    J Egypt Soc Parasitol; 1989 Dec; 19(2):605-10. PubMed ID: 2504826
    [Abstract] [Full Text] [Related]

  • 12. Nature of progressive glomerulosclerosis in human membranous nephropathy.
    Lee HS, Koh HI.
    Clin Nephrol; 1993 Jan; 39(1):7-16. PubMed ID: 8428410
    [Abstract] [Full Text] [Related]

  • 13. Concurrent focal segmental glomerulosclerosis and membranous nephropathy.
    Amenta PS, Swartz C, Katz SM.
    Clin Nephrol; 1989 Oct; 32(4):173-7. PubMed ID: 2639671
    [Abstract] [Full Text] [Related]

  • 14. Schistosomal specific nephropathy leading to end-stage renal failure.
    Sobh MA, Moustafa FE, el-Housseini F, Basta MT, Deelder AM, Ghoniem MA.
    Kidney Int; 1987 Apr; 31(4):1006-11. PubMed ID: 3108566
    [Abstract] [Full Text] [Related]

  • 15. The impact of sex in primary glomerulonephritis.
    Cattran DC, Reich HN, Beanlands HJ, Miller JA, Scholey JW, Troyanov S, Genes, Gender and Glomerulonephritis Group.
    Nephrol Dial Transplant; 2008 Jul; 23(7):2247-53. PubMed ID: 18182409
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infection: a controlled trial.
    Ferrari ML, Coelho PM, Antunes CM, Tavares CA, da Cunha AS.
    Bull World Health Organ; 2003 Jul; 81(3):190-6. PubMed ID: 12764515
    [Abstract] [Full Text] [Related]

  • 17. Double-blind clinical trial comparing praziquantel with oxamniquine in the treatment of patients with schistosomiasis mansoni.
    Branchini ML, Pedro Rde J, Dias LC, Deberaldini ER.
    Rev Inst Med Trop Sao Paulo; 1982 Jul; 24(5):315-21. PubMed ID: 6762635
    [No Abstract] [Full Text] [Related]

  • 18. Effects of praziquantel and oxamniquine on a Saudi Arabian strain of Schistosoma mansoni in mice.
    Ghandour AM, Banaja AA, Shalaby IM.
    J Helminthol; 1990 Mar; 64(1):62-4. PubMed ID: 2110944
    [Abstract] [Full Text] [Related]

  • 19. Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants.
    Chun MJ, Korbet SM, Schwartz MM, Lewis EJ.
    J Am Soc Nephrol; 2004 Aug; 15(8):2169-77. PubMed ID: 15284302
    [Abstract] [Full Text] [Related]

  • 20. [Treatment of idiopathic membranous nephropathy. Is the anti-CD20 antibody rituximab a reasonable option?].
    Busch M, Gerth J, Ott U, Schip A, Haufe CC, Gröne HJ, Wolf G.
    Med Klin (Munich); 2008 Jul 15; 103(7):519-24. PubMed ID: 18604487
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.